Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Peritoneal and Retroperitoneal Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Peritoneal and Retroperitoneal Neoplasm

Cancer Family

Peritoneal and Retroperitoneal Neoplasm

CI-CAN-00000045Explore in graph →

Non-malignant207 active trials6 approved drugs6 evidence items

NCIt: C7337

Overview
Statistics
Survival
Genomics4
Variants & evidence6
Drugs7
Trials887
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (5)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 26, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 1–5 of 5 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Clinical implications of novel activating EGFR mutations in malignant peritoneal mesothelioma.
· World J Surg Oncol · 2010 · PMID 20942962 · validated civic_curation pubmed
Mutation and methylation analysis of TP53 in adrenal carcinogenesis.
· Eur J Surg Oncol · 2005 · PMID 15922892 · validated civic_curation pubmed
Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing.
· PLoS One · 2015 · PMID 25798586 · validated civic_curation pubmed
Germline mutations in the vhl gene in patients presenting with phaeochromocytomas.
· Int J Cancer · 1998 · PMID 9663592 · validated civic_curation pubmed
Case Report: triple therapy with pembrolizumab, ipilimumab, and lenvatinib in mitotane- and radiation-refractory, cortisol-secreting stage IV adrenocortical carcinoma: a genomically guided approach.
· Front Immunol · 2026 · PMID 42158873 · validated civic_curation pubmed

Showing 1–5 of 5 publications